Clear Creek Bio initiates dosing for Covid-19 drug trial
The study subjects will be given once daily dose of brequinar or placebo for five days. Credit: James Yarema on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
